Sea Mild Biotechnology Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 10, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	205	237	220	73	154	234
Market Cap Growth	-12.03%	7.90%	200.00%	-52.50%	-33.90%	-24.31%
Enterprise Value	230	242	215	64	144	215
Last Close Price	10.60	12.30	11.40	3.80	8.00	12.10
PE Ratio	9.55	7.43	35.58	-	-	-
PS Ratio	0.59	0.75	0.86	0.36	0.94	1.12
PB Ratio	1.90	2.32	3.13	1.14	1.80	1.70
P/TBV Ratio	1.90	2.32	3.13	1.14	1.82	1.72
P/FCF Ratio	19.57	10.41	29.00	6.27	-	-
P/OCF Ratio	8.17	6.93	24.91	6.27	-	52.12
EV/Sales Ratio	0.66	0.76	0.84	0.32	0.88	1.03
EV/EBITDA Ratio	5.55	8.59	29.18	-	-	-
EV/EBIT Ratio	12.04	10.84	44.56	-	-	-
EV/FCF Ratio	21.99	10.58	28.37	5.46	-	-
Debt / Equity Ratio	0.83	0.56	0.63	0.39	0.29	0.25
Debt / EBITDA Ratio	2.15	1.39	2.29	7.95	-	-
Debt / FCF Ratio	8.52	2.52	5.83	2.17	-	-
Net Debt / Equity Ratio	0.24	-0.25	-0.03	-0.24	-0.16	-0.13
Net Debt / EBITDA Ratio	0.87	-0.91	-0.32	1.97	0.63	0.65
Net Debt / FCF Ratio	2.42	-1.12	-0.31	-1.30	0.91	3.03
Asset Turnover	1.33	1.43	1.48	1.24	0.79	0.68
Inventory Turnover	5.48	5.24	8.81	8.79	5.82	5.31
Quick Ratio	1.08	0.98	0.92	1.21	1.37	1.16
Current Ratio	1.52	1.45	1.33	1.51	1.74	1.80
Return on Equity (ROE)	22.11%	37.02%	9.17%	-28.45%	-46.54%	-33.62%
Return on Assets (ROA)	4.54%	6.24%	1.74%	-4.59%	-9.58%	-7.47%
Return on Invested Capital (ROIC)	13.76%	29.86%	8.24%	-19.76%	-33.35%	-22.19%
Return on Capital Employed (ROCE)	13.50%	21.00%	6.30%	-15.70%	-31.00%	-22.60%
Earnings Yield	10.47%	13.47%	2.81%	-29.14%	-33.70%	-23.75%
FCF Yield	5.11%	9.61%	3.45%	15.96%	-9.84%	-2.55%
Buyback Yield / Dilution	-	-	-	-	-	-1.16%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.